IO BIOTECH INC. - COMMON STOCK
N/A
31-12月-69 19:00:00
15 分の遅延
株式
N/A
本日の幅
N/A - N/A
ISIN
N/A
ソース
NASDAQ
-
IO Biotech Announces Achievement of Significant Phase 3 Clinical Trial Recruitment Milestone
14 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
01 6 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
IO Biotech to Present at the Jefferies Healthcare Conference
30 5 2023 16:35:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 First-Quarter Results
11 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces 2022 Fourth-Quarter and Year-End Results
14 3 2023 16:11:47 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in March 2023 Investor Conferences
22 2 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Appointment of Devin Smith as General Counsel
23 1 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
IO Biotech Provides Business Update
09 1 2023 07:05:46 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Third Quarter Results for 2022
09 11 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Jefferies London Healthcare Conference
31 10 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Appointment of New Chief Financial Officer
13 10 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
05 10 2022 08:05:00 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
06 9 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Second Quarter Results for 2022
11 8 2022 17:00:18 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in the 2022 BIO International Convention
06 6 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
26 5 2022 17:00:00 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Jefferies Healthcare Conference
23 5 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
18 5 2022 07:00:00 提供 Nasdaq GlobeNewswire